负面清单法干预注射用单磷酸阿糖腺苷不合理用药的效果分析

发布时间：2018-04-06 02:12

本文选题：负面清单法　切入点：单磷酸阿糖腺苷　出处：《中国医院药学杂志》2017年19期

【摘要】：目的:探讨负面清单法干预注射用单磷酸阿糖腺苷临床用药的效果。方法:分析某院注射用单磷酸阿糖腺苷的临床使用现状,利用负面清单法进行干预,总结干预后不合理用药改进效果。结果:注射用单磷酸阿糖腺苷不合理用药集中表现在适应证方面,如超适应证、无适应证和诊断不明确三方面。干预后,不合理率由干预前99.43%降至34.12%。其中超适应证现象由85例(48.57%)降为14例(16.47%);诊断不明确从78例(44.57%)降至7例(8.24%);无适应证给药由11例(6.29%)降为8例(9.41)%。结论:负面清单法规范该院注射用单磷酸阿糖腺苷的临床应用效果显著,值得进一步推广用于合理用药质量管理。
[Abstract]:Objective: to investigate the effect of negative list method on the treatment of adenosine arabinoside monophosphate for injection.Methods: the clinical application of adenosine monophosphate for injection in a hospital was analyzed. The negative list method was used to intervene and summarize the effect of irrational drug use after intervention.Results: the irrational use of adenosine arabinate monophosphate for injection focused on the indications, such as overindication, lack of indication and unclear diagnosis.After intervention, the unreasonable rate decreased from 99.43% before intervention to 34.12%.The overindication was reduced from 85 cases (48.57 cases) to 14 cases (16.47%), the diagnostic uncertainty decreased from 78 cases (44.57) to 7 cases (8.24%), and the number of cases without indication decreased from 11 cases (6.29 cases) to 8 cases (9.41%).Conclusion: the negative list method is effective in clinical application of adenosine arabinophosphate for injection in our hospital, and it is worth popularizing for rational drug use quality management.
【作者单位】：蚌埠医学院第二附属医院药剂科;
【分类号】：R95

【相似文献】